The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction
The EMBO Journal (2006) 25, 3774–3783, doi:10.1038/sj.emboj.7601263
Published online 3 August 2006
MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage
Deepak Raina1, Rehan Ahmad1, Shailendra Kumar2, Jian Ren, Kiyotsugu Yoshida3, Surender Kharbanda and Donald Kufe
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

To whom correspondence should be addressed
Donald Kufe, Dana-Farber Cancer Institute, Harvard Medical School, Binny Street, Boston, MA 02115, USA. Tel.: +1 617 632 3141 Fax: +1 617 632 2934; E-mail: donald_kufe@dfci.harvard.edu

1 These authors contributed equally to this work
2 Present address: Matritech Inc., Newton, MA 02460, USA
3 Present address: Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

Received 15 December 2005; Accepted 7 July 2006; Published online 3 August 2006.
Abstract
The nonreceptor c-Abl tyrosine kinase binds to cytosolic 14-3-3 proteins and is targeted to the nucleus in the apoptotic response to DNA damage. The MUC1 oncoprotein is overexpressed by most human carcinomas and blocks the induction of apoptosis by genotoxic agents. Using human carcinoma cells with gain and loss of MUC1 function, we show that nuclear targeting of c-Abl by DNA damage is abrogated by a MUC1-dependent mechanism. The results demonstrate that c-Abl phosphorylates MUC1 on Tyr-60 and forms a complex with MUC1 by binding of the c-Abl SH2 domain to the pTyr-60 site. Binding of MUC1 to c-Abl attenuates phosphorylation of c-Abl on Thr-735 and the interaction between c-Abl and cytosolic 14-3-3. We also show that expression of MUC1 with a mutation at Tyr-60 (i) disrupts the interaction between MUC1 and c-Abl, (ii) relieves the MUC1-induced block of c-Abl phosphorylation on Thr-735 and binding to 14-3-3, and (iii) attenuates the MUC1 antiapoptotic function. These findings indicate that MUC1 sequesters c-Abl in the cytoplasm and thereby inhibits apoptosis in the response to genotoxic anticancer agents.
Keywords: apoptosis, c-Abl, DNA damage, MUC1, 14-3-3
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Stress and death: breaking up the c-Abl/14-3-3 complex in apoptosis

Nature Cell Biology News and Views (01 Mar 2005)

Cancer DNA damage enables p73

Nature News and Views (24 Jun 1999)

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization